We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-concept

Product News   Jan 28, 2020

 
TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-concept
FURTHER INFORMATION
 
 
 

Related Product News

Custom CAR-T Development Service

Product News

AMSBIO has announced a custom Chimeric Antigen Receptor T cell (CAR-T) service designed to take advantage of the clinical breakthroughs achieved with CAR-T cells in various hematological malignancies.

READ MORE

Collaborative to Fund Lung Cancer Immunotherapy Clinical Trial

Product News

Vaccitech has announced that it has entered into a clinical partnership with Cancer Research UK to develop a novel immunotherapy as a treatment option for patients with non-small cell lung cancer.

READ MORE

BioAscent Collaborates To Identify Potential Cancer Treatments

Product News

BioAscent scientists have helped to discover potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE